Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Grifols S.A. (GRFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,858,164
  • Shares Outstanding, K 682,820
  • Annual Sales, $ 4,482 M
  • Annual Income, $ 603,600 K
  • 36-Month Beta 1.04
  • Price/Sales 3.28
  • Price/Cash Flow 16.13
  • Price/Book 3.74

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.31 +2.11%
on 12/12/17
23.30 -6.61%
on 11/22/17
-1.04 (-4.56%)
since 11/13/17
3-Month
20.45 +6.41%
on 09/21/17
24.20 -10.08%
on 11/03/17
+0.06 (+0.28%)
since 09/13/17
52-Week
14.58 +49.25%
on 12/14/16
24.20 -10.08%
on 11/03/17
+7.20 (+49.45%)
since 12/13/16

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience...

See More

Key Turning Points

2nd Resistance Point 22.08
1st Resistance Point 21.92
Last Price 21.76
1st Support Level 21.54
2nd Support Level 21.32

See More

52-Week High 24.20
Last Price 21.76
Fibonacci 61.8% 20.53
Fibonacci 50% 19.39
Fibonacci 38.2% 18.25
52-Week Low 14.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.